BARKA Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 44860627
Slotsmarken 11, 2970 Hørsholm
kab@hannibal-innovation.com
tel: 21678077
Income statement (kDKK)
2024 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| External services | -50.82 |
| Gross profit | -50.82 |
| EBIT | -50.82 |
| Other financial expenses | -70.36 |
| Pre-tax profit | - 121.18 |
| Income taxes | 6.74 |
| Net earnings | - 114.44 |
Assets (kDKK)
2024 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Current other receivables | 7.66 |
| Current deferred tax assets | 6.74 |
| Short term receivables total | 14.39 |
| Cash and bank deposits | 1 584.80 |
| Cash and cash equivalents | 1 584.80 |
| Balance sheet total (assets) | 1 599.19 |
Equity and liabilities (kDKK)
2024 | |
|---|---|
| Share capital | 60.00 |
| Share premium account | 330.00 |
| Profit of the financial year | - 114.44 |
| Shareholders equity total | 275.56 |
| Non-current deferred tax liabilities | 1 270.36 |
| Non-current liabilities total | 1 270.36 |
| Current trade creditors | 53.28 |
| Current liabilities total | 53.28 |
| Balance sheet total (liabilities) | 1 599.19 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.